• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis.

作者信息

Chen Ao, Hou Wolin, Zhang Yunhe, Chen Yingmin, He Ben

机构信息

Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Medical Center of Diabetes, Shanghai Key Clinical Center of Metabolic Diseases, Shanghai Institute for Diabetes, Shanghai Key Laboratory of Diabetes, Shanghai, China.

出版信息

Int J Cardiol. 2015 Mar 1;182:168-70. doi: 10.1016/j.ijcard.2014.12.137. Epub 2014 Dec 30.

DOI:10.1016/j.ijcard.2014.12.137
PMID:25577755
Abstract
摘要

相似文献

1
Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis.血清半乳糖凝集素-3在心力衰竭患者中的预后价值：一项荟萃分析。
Int J Cardiol. 2015 Mar 1;182:168-70. doi: 10.1016/j.ijcard.2014.12.137. Epub 2014 Dec 30.
2
Prognostic value of galectin-3 in patients with heart failure.半乳糖凝集素-3在心力衰竭患者中的预后价值。
Dis Markers. 2015;2015:690205. doi: 10.1155/2015/690205. Epub 2015 Apr 16.
3
Galectin-3, a prognostic marker--and a therapeutic target?半乳糖凝集素-3，一种预后标志物——也是治疗靶点？
Rev Port Cardiol. 2015 Mar;34(3):201-8. doi: 10.1016/j.repc.2014.10.005. Epub 2015 Mar 3.
4
Comprehensive review of the prognostic value of galectin-3 in heart failure.半乳糖凝集素-3在心力衰竭中预后价值的综合综述。
Cardiol Rev. 2014 Jul-Aug;22(4):171-5. doi: 10.1097/CRD.0000000000000013.
5
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients.成纤维细胞生长因子23、可溶性ST2和半乳糖凝集素-3对心力衰竭患者心血管死亡预后的比较
Int J Cardiol. 2015 Jun 15;189:185-7. doi: 10.1016/j.ijcard.2015.04.074. Epub 2015 Apr 11.
6
The predictive value of plasma biomarkers in discharged heart failure patients: role of galectin-3.血浆生物标志物对出院心力衰竭患者的预测价值：半乳糖凝集素-3的作用
Minerva Cardioangiol. 2016 Apr;64(2):181-94. Epub 2015 Sep 30.
7
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.心力衰竭患者半乳糖凝集素-3 的基线和连续测量：与预后的关系以及缬沙坦治疗对 Val-HeFT 的影响。
Eur J Heart Fail. 2013 May;15(5):511-8. doi: 10.1093/eurjhf/hfs205. Epub 2013 Jan 4.
8
Galectin-3 in Heart Failure: An Update of the Last 3 Years.心力衰竭中的半乳糖凝集素-3：过去三年的最新进展
Heart Fail Clin. 2018 Jan;14(1):75-92. doi: 10.1016/j.hfc.2017.08.009.
9
Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure.血浆半乳糖凝集素-3水平在冠心病和慢性心力衰竭患者中的预后价值。
Int Heart J. 2015 May 13;56(3):314-8. doi: 10.1536/ihj.14-304. Epub 2015 Apr 23.
10
Short-term Serial Measurement of Galectin-3 in Hospitalized Patients With Acute Heart Failure.急性心力衰竭住院患者半乳糖凝集素-3的短期连续测量
Rev Esp Cardiol (Engl Ed). 2018 May;71(5):401-402. doi: 10.1016/j.rec.2017.03.013. Epub 2017 May 1.

引用本文的文献

1
Evolving role of myocardial fibrosis in heart failure with preserved ejection fraction.心肌纤维化在射血分数保留的心力衰竭中的演变作用。
Front Cardiovasc Med. 2025 Apr 23;12:1573346. doi: 10.3389/fcvm.2025.1573346. eCollection 2025.
2
Evaluation of serum galectin-3 concentration as a potential biomarker in exudative-type age-related macular degeneration.评估血清半乳糖凝集素-3浓度作为渗出型年龄相关性黄斑变性潜在生物标志物的作用。
Sci Rep. 2024 Dec 30;14(1):31957. doi: 10.1038/s41598-024-83499-w.
3
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.
心血管疾病管理的综合述评：心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
4
Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy.用于心脏病风险分层的血清生物标志物的最新进展以及对接受靶向治疗的血液系统恶性肿瘤患者心脏管理的见解。
Cureus. 2023 Nov 30;15(11):e49696. doi: 10.7759/cureus.49696. eCollection 2023 Nov.
5
Galectin-3 changes from admission to discharge and its prognostic value for in-hospital mortality in heart failure: A prospective observational study.入院至出院期间半乳糖凝集素-3 的变化及其对心力衰竭住院死亡率的预后价值：一项前瞻性观察研究。
Medicine (Baltimore). 2023 May 19;102(20):e33804. doi: 10.1097/MD.0000000000033804.
6
The Influence of Body Mass Index on Clinical Interpretation of Established and Novel Biomarkers in Acute Heart Failure.体重指数对急性心力衰竭中既定和新型生物标志物临床解读的影响。
J Card Fail. 2023 Aug;29(8):1121-1131. doi: 10.1016/j.cardfail.2023.03.029. Epub 2023 Apr 29.
7
Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance.半乳糖凝集素-3 和血型：结合特性、对血浆水平的影响及其对预后性能的影响。
Int J Mol Sci. 2023 Feb 23;24(5):4415. doi: 10.3390/ijms24054415.
8
Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology.心血管肿瘤学中用于风险分层和患者管理的血清生物标志物的最新进展。
Curr Cardiol Rep. 2023 Mar;25(3):133-146. doi: 10.1007/s11886-022-01834-x. Epub 2023 Feb 15.
9
Levels of Galectin-3 in Chronic Heart Failure: A Case-Control Study.慢性心力衰竭患者中半乳糖凝集素-3水平：一项病例对照研究。
Cureus. 2022 Aug 23;14(8):e28310. doi: 10.7759/cureus.28310. eCollection 2022 Aug.
10
Predictive Value of Galectin-3 and Brachial-Ankle Pulse Wave Velocity for Coronary Artery Calcification in Coronary Arteriography Patients.半乳糖凝集素-3 和肱踝脉搏波速度对冠状动脉造影患者冠状动脉钙化的预测价值。
Int J Clin Pract. 2022 May 16;2022:1865736. doi: 10.1155/2022/1865736. eCollection 2022.